White label ELPA - ClinicalTrials.eu

Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

Not recruiting

3 1 1
Investigated diseases:
- Dermatomyositis
Investigated drugs:
- Human Normal Immunoglobulin
+1
Study on Patidegib Gel for Reducing Basal Cell Carcinomas in Adults with Gorlin Syndrome

Not recruiting

3 1
Investigated diseases:
- Basal cell naevus syndrome
Investigated drugs:
- Patidegib Hydrochloride Isopropanolate
Study on Idiopathic Pulmonary Fibrosis: Evaluating Pirfenidone and Nintedanib for Patients with Progressive Disease

Not recruiting

3 1 1 1
Investigated diseases:
- Idiopathic pulmonary fibrosis
Investigated drugs:
- Nintedanib
- Pirfenidone
Study of Axitinib and Immune Checkpoint Inhibitors for Patients with Untreated Advanced or Metastatic Kidney Cancer

Not recruiting

2 1 1 1
Study on Metformin for Pain Relief in Patients with Hand Osteoarthritis

Not recruiting

3 1 1
Investigated diseases:
- Nodal osteoarthritis
- Osteoarthritis
Investigated drugs:
- Metformin Hydrochloride
Study on the Effects of Ponsegromab on Quality of Life and Safety in Adults with Heart Failure

Not recruiting

2 1
Investigated drugs:
- Ponsegromab
Study Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
+10
Study on the Safety and Effects of BNT314 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

Not recruiting

1 1 1
Investigated diseases:
- Malignant mast cell neoplasm
Investigated drugs:
- Bnt314
Study on the Safety and Effectiveness of Cenegermin Eye Drops for Patients with Dry Eye Disease

Not recruiting

2 1 1
Investigated diseases:
- Dry eye
Investigated drugs:
Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Not recruiting

3 1
Investigated diseases:
- Cardiac amyloidosis
Investigated drugs:
- Alxn2220
+8

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies